vs
Side-by-side financial comparison of J.Jill, Inc. (JILL) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
J.Jill, Inc. is the larger business by last-quarter revenue ($150.5M vs $75.5M, roughly 2.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.5%). J.Jill, Inc. produced more free cash flow last quarter ($16.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.1%).
J.Jill is an American womenswear retailer founded in 1955 in Massachusetts. It has been a publicly traded company since 2017. J.Jill is headquartered in Quincy, Massachusetts.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
JILL vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $150.5M | $75.5M |
| Net Profit | $9.2M | — |
| Gross Margin | 70.9% | 69.3% |
| Operating Margin | 9.9% | 22.7% |
| Net Margin | 6.1% | — |
| Revenue YoY | -0.5% | 27.7% |
| Net Profit YoY | -25.5% | — |
| EPS (diluted) | $0.60 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $150.5M | $75.5M | ||
| Q3 25 | $154.0M | $54.5M | ||
| Q2 25 | $153.6M | $52.4M | ||
| Q1 25 | $142.8M | $46.0M | ||
| Q4 24 | $151.3M | $59.1M | ||
| Q3 24 | $155.2M | $80.5M | ||
| Q2 24 | $161.5M | $47.1M | ||
| Q1 24 | $150.3M | $43.8M |
| Q4 25 | $9.2M | — | ||
| Q3 25 | $10.5M | $8.8M | ||
| Q2 25 | $11.7M | $5.9M | ||
| Q1 25 | $2.2M | $3.0M | ||
| Q4 24 | $12.3M | — | ||
| Q3 24 | $8.2M | $20.3M | ||
| Q2 24 | $16.7M | $-4.5M | ||
| Q1 24 | $4.8M | $-4.8M |
| Q4 25 | 70.9% | 69.3% | ||
| Q3 25 | 68.4% | 77.7% | ||
| Q2 25 | 71.8% | 76.5% | ||
| Q1 25 | 66.3% | 77.1% | ||
| Q4 24 | 71.4% | 76.4% | ||
| Q3 24 | 70.5% | 63.9% | ||
| Q2 24 | 72.9% | 77.4% | ||
| Q1 24 | 67.5% | 75.5% |
| Q4 25 | 9.9% | 22.7% | ||
| Q3 25 | 10.9% | 17.6% | ||
| Q2 25 | 12.4% | 12.7% | ||
| Q1 25 | 3.6% | 8.7% | ||
| Q4 24 | 12.7% | 22.6% | ||
| Q3 24 | 14.8% | 27.4% | ||
| Q2 24 | 17.6% | -4.6% | ||
| Q1 24 | 7.0% | -5.3% |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 6.8% | 16.2% | ||
| Q2 25 | 7.6% | 11.2% | ||
| Q1 25 | 1.6% | 6.5% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 5.3% | 25.2% | ||
| Q2 24 | 10.3% | -9.6% | ||
| Q1 24 | 3.2% | -11.0% |
| Q4 25 | $0.60 | $0.26 | ||
| Q3 25 | $0.69 | $0.17 | ||
| Q2 25 | $0.76 | $0.12 | ||
| Q1 25 | $0.11 | $0.06 | ||
| Q4 24 | $0.80 | $0.40 | ||
| Q3 24 | $0.54 | $0.41 | ||
| Q2 24 | $1.16 | $-0.09 | ||
| Q1 24 | $0.33 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.0M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $129.0M | $130.3M |
| Total Assets | $458.0M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.0M | $97.5M | ||
| Q3 25 | $45.5M | $94.4M | ||
| Q2 25 | $31.2M | $96.0M | ||
| Q1 25 | $35.4M | $93.2M | ||
| Q4 24 | $38.8M | $101.0M | ||
| Q3 24 | $28.5M | $96.7M | ||
| Q2 24 | $77.1M | $96.8M | ||
| Q1 24 | $62.2M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $129.0M | $130.3M | ||
| Q3 25 | $121.5M | $115.3M | ||
| Q2 25 | $112.0M | $104.7M | ||
| Q1 25 | $105.8M | $97.1M | ||
| Q4 24 | $103.3M | $92.1M | ||
| Q3 24 | $90.4M | $71.1M | ||
| Q2 24 | $53.1M | $48.5M | ||
| Q1 24 | $37.2M | $51.0M |
| Q4 25 | $458.0M | $216.3M | ||
| Q3 25 | $436.5M | $202.9M | ||
| Q2 25 | $432.9M | $194.9M | ||
| Q1 25 | $417.7M | $196.2M | ||
| Q4 24 | $418.3M | $213.3M | ||
| Q3 24 | $390.8M | $220.7M | ||
| Q2 24 | $443.9M | $205.0M | ||
| Q1 24 | $428.2M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.1M | $14.4M |
| Free Cash FlowOCF − Capex | $16.0M | $14.4M |
| FCF MarginFCF / Revenue | 10.6% | 19.1% |
| Capex IntensityCapex / Revenue | 2.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.07× | — |
| TTM Free Cash FlowTrailing 4 quarters | $37.6M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.1M | $14.4M | ||
| Q3 25 | $19.4M | $9.7M | ||
| Q2 25 | $5.3M | $14.1M | ||
| Q1 25 | $8.1M | $3.6M | ||
| Q4 24 | $19.1M | $15.6M | ||
| Q3 24 | $16.4M | $11.0M | ||
| Q2 24 | $21.5M | $1.0M | ||
| Q1 24 | $6.6M | $11.2M |
| Q4 25 | $16.0M | $14.4M | ||
| Q3 25 | $17.1M | $9.7M | ||
| Q2 25 | $3.1M | $14.1M | ||
| Q1 25 | $1.4M | $3.6M | ||
| Q4 24 | $14.6M | $15.6M | ||
| Q3 24 | $15.0M | $11.0M | ||
| Q2 24 | $19.8M | $1.0M | ||
| Q1 24 | $1.8M | — |
| Q4 25 | 10.6% | 19.1% | ||
| Q3 25 | 11.1% | 17.7% | ||
| Q2 25 | 2.0% | 26.8% | ||
| Q1 25 | 1.0% | 7.7% | ||
| Q4 24 | 9.7% | 26.4% | ||
| Q3 24 | 9.6% | 13.7% | ||
| Q2 24 | 12.2% | 2.1% | ||
| Q1 24 | 1.2% | — |
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 1.5% | 0.0% | ||
| Q2 25 | 1.5% | 0.0% | ||
| Q1 25 | 4.7% | 0.1% | ||
| Q4 24 | 2.9% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 3.2% | 0.0% |
| Q4 25 | 2.07× | — | ||
| Q3 25 | 1.84× | 1.10× | ||
| Q2 25 | 0.46× | 2.41× | ||
| Q1 25 | 3.60× | 1.21× | ||
| Q4 24 | 1.54× | — | ||
| Q3 24 | 2.00× | 0.54× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | 1.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JILL
| Sales Channel Through Intermediary | $80.1M | 53% |
| Sales Channel Directly To Consumer | $70.5M | 47% |
PBYI
Segment breakdown not available.
